Torthaí cuardaigh - Relecom, Allan
- 1 - 5 toradh as 5 á dtaispeáint
-
1
Emerging dynamics pathways of response and resistance to PD-1 and CTLA-4 blockade: tackling uncertainty by confronting complexity de réir Relecom, Allan, Merhi, Maysaloun, Inchakalody, Varghese, Uddin, Shahab, Rinchai, Darawan, Bedognetti, Davide, Dermime, Said
Foilsithe / Cruthaithe 2021Téacs -
2
Screening Status as a Determinant of Choice of Colorectal Cancer Screening Method: A Population-Based Informed Survey de réir Sandoval, José Luis, Relecom, Allan, Ducros, Cyril, Bulliard, Jean-Luc, Arzel, Beatrice, Guessous, Idris
Foilsithe / Cruthaithe 2021Téacs -
3
Unleashing the immune response to NY-ESO-1 cancer testis antigen as a potential target for cancer immunotherapy de réir Raza, Afsheen, Merhi, Maysaloun, Inchakalody, Varghese Philipose, Krishnankutty, Roopesh, Relecom, Allan, Uddin, Shahab, Dermime, Said
Foilsithe / Cruthaithe 2020Téacs -
4
Resources-Stratified Guidelines for Classical Hodgkin Lymphoma de réir Relecom, Allan, Federico, Massimo, Connors, Joseph M., Coiffier, Bertrand, Biasoli, Irene, Moccia, Alden, Salles, Gilles, McKee, Thomas, Miralbell, Raymond, Borchmann, Peter, Kuruvilla, John, Johnson, Peter, Cavalli, Franco, Delavy, Martine, Dietrich, Pierre-Yves, Flahault, Antoine
Foilsithe / Cruthaithe 2020Téacs -
5
Persistent anti-NY-ESO-1-specific T cells and expression of differential biomarkers in a patient with metastatic gastric cancer benefiting from combined radioimmunotherapy treatmen... de réir Merhi, Maysaloun, Raza, Afsheen, Inchakalody, Varghese Philipose, Siveen, Kodappully S, Kumar, Deepak, Sahir, Fairooz, Mestiri, Sarra, Hydrose, Shereena, Allahverdi, Niloofar, Jalis, Munir, Relecom, Allan, Al Zaidan, Lobna, Hamid, Mohamed Sir Elkhatim, Mostafa, Mai, Gul, Abdul Rehman Zar, Uddin, Shahab, Al Homsi, Mohammed, Dermime, Said
Foilsithe / Cruthaithe 2020Téacs